{"id":5444,"date":"2018-09-20T12:45:20","date_gmt":"2018-09-20T10:45:20","guid":{"rendered":"http:\/\/www.rapharm.eu\/en\/?p=5444"},"modified":"2018-09-20T12:45:20","modified_gmt":"2018-09-20T10:45:20","slug":"new-eu-legislation-effect-on-medical-devices-distributors-liabilities","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/en\/new-eu-legislation-effect-on-medical-devices-distributors-liabilities\/","title":{"rendered":"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES"},"content":{"rendered":"<style type=\"text\/css\"><\/style><p><strong>29th &amp;\u00a030th November 2018<\/strong><br \/>\n<strong>Radon Plaza Hotel\u00a0Sarajevo, BIH (Croatian-Serbian-Bosnian-Montenegrian\u00a0jezik)<\/strong><\/p>\n<p><strong>International regulatory seminar and workshop<br \/>\nNEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES<br \/>\n<\/strong><\/p>\n<p>New EU regulations on medical devices will affect economic operators operating in the EU and their partners outside the EU, not only because of the harmonization of regulations, but also due to the increasing direction of EU manufacturers to deal with importers and distributors outside the EU that meet the same service standards and mutual relations as in the EU. It is therefore important to correctly understand the new requirements and their potential impact on business, and to prevent unpleasant surprises in practice. In particular, the sensitive area of new distributors&#8217; liabilities relative to other partners should be highlighted. EU distributors are seriously accepting the advice to review existing contracts in the light of new requirements. Finding weak points often means avoiding existential problems.<\/p>\n<p><strong>Click\u00a0<a href=\"http:\/\/www.rapharm.eu\/wp-content\/uploads\/2018\/09\/SeminarRadionicaDistributeri2930112018.pdf\" target=\"_blank\">HERE<\/a>\u00a0for more information on seminar and workshop.<\/strong><\/p>\n<p><strong>Click\u00a0<a href=\"http:\/\/www.rapharm.eu\/en\/apply-for-education\/\" target=\"_blank\">HERE<\/a>\u00a0to apply for seminar and workshop.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>29th &amp;\u00a030th November 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (Croatian-Serbian-Bosnian-Montenegrian\u00a0jezik) International regulatory seminar and workshop NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES New EU regulations on medical devices will affect economic operators operating in the EU and their partners outside the EU, not only because of the harmonization of regulations, but also due to&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40,39,30],"tags":[],"class_list":["post-5444","post","type-post","status-publish","format-standard","hentry","category-current-educations-and-trainings","category-regulatory-news","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#039; LIABILITIES - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#039; LIABILITIES - raPHARM\" \/>\n<meta property=\"og:description\" content=\"29th &amp;\u00a030th November 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (Croatian-Serbian-Bosnian-Montenegrian\u00a0jezik) International regulatory seminar and workshop NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES New EU regulations on medical devices will affect economic operators operating in the EU and their partners outside the EU, not only because of the harmonization of regulations, but also due to...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-20T10:45:20+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\",\"url\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\",\"name\":\"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS' LIABILITIES - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2018-09-20T10:45:20+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS' LIABILITIES - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","og_locale":"en_US","og_type":"article","og_title":"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS' LIABILITIES - raPHARM","og_description":"29th &amp;\u00a030th November 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (Croatian-Serbian-Bosnian-Montenegrian\u00a0jezik) International regulatory seminar and workshop NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES New EU regulations on medical devices will affect economic operators operating in the EU and their partners outside the EU, not only because of the harmonization of regulations, but also due to...","og_url":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","og_site_name":"raPHARM","article_published_time":"2018-09-20T10:45:20+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","url":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","name":"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS' LIABILITIES - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2018-09-20T10:45:20+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/en\/"},{"@type":"ListItem","position":2,"name":"International regulatory seminar and workshop: NEW EU LEGISLATION EFFECT ON MEDICAL DEVICES DISTRIBUTORS&#8217; LIABILITIES"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/5444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/comments?post=5444"}],"version-history":[{"count":3,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/5444\/revisions"}],"predecessor-version":[{"id":5447,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/5444\/revisions\/5447"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/media?parent=5444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/categories?post=5444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/tags?post=5444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}